Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026 and Sep 2026.
- Largest single sale: $641K (8,366 shares) of Tarsus Pharmaceuticals, Inc. on Mar 4, 2026. Filing
- Last sale before this period: Mar 20, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | Oct 15, 2020 | Sep 9, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 4, 2026, Tarsus Pharmaceuticals, Inc.: sold 4,564 shares for $388K, under a disclosed plan. 1 filing: 1
- Mar 20, 2026, Tarsus Pharmaceuticals, Inc.: sold 2,989 shares for $200K, under a disclosed plan. 1 filing: 1
- Mar 19, 2026, Tarsus Pharmaceuticals, Inc.: sold 4,589 shares for $307K, to cover taxes. 1 filing: 1
- Mar 18, 2026, Tarsus Pharmaceuticals, Inc.: sold 3,610 shares for $248K, to cover taxes. 1 filing: 1
- Mar 17, 2026, Tarsus Pharmaceuticals, Inc.: sold 3,125 shares for $217K, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.